Cambridge, MA, United States of America

Zhan Wang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Flagship Pioneering Innovations Vi, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhan Wang. Retrieved from https://idiyas.com/inventor/zhan-wang-k7kx6wxy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhan Wang - Innovator in Gene Modifying Technologies

Introduction

Zhan Wang is a prominent inventor based in Cambridge, MA, known for his contributions to gene modifying technologies. He has made significant strides in the field of biotechnology, particularly in developing methods for editing and modifying genetic material.

Latest Patents

Zhan Wang holds a patent for "PAH-modulating compositions and methods." This patent provides compositions, systems, and methods for targeting, editing, modifying, or manipulating a host cell's genome at specific locations within a DNA sequence. The technology is particularly relevant for treating phenylketonuria (PKU), a genetic disorder that affects the metabolism of phenylalanine.

Career Highlights

Zhan Wang is associated with Flagship Pioneering Innovations Vi, LLC, where he continues to advance his research and development efforts. His work focuses on innovative solutions that have the potential to transform the landscape of genetic therapies.

Collaborations

Zhan Wang collaborates with notable professionals in the field, including Robert Charles Altshuler and Anne Helen Bothmer. These partnerships enhance the scope and impact of his research initiatives.

Conclusion

Zhan Wang's innovative work in gene modifying technologies positions him as a key figure in the biotechnology sector. His contributions are paving the way for new treatments and therapies that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…